Pharmaceutical patents are notoriously long and complex. It’s not uncommon for scientists or analysts to spend days—or even weeks—manually reviewing a single 300-page patent just to extract a few key molecules or data points. But what if this process could be reduced to minutes? The Problem with Manual Pharmaceutical Patent Analysis Traditional patent analysis involves: This leads to: A Faster Approach: AI for pharmaceutical patent analysis Instead of manually parsing patents, AI can: For example, with AI-powered tools like Eureka LS Lead Compound Agent: Real Impact Instead of: Spending 1 week reading a patent You can: Get a structured, decision-ready…